Meet Our Team
Dr. Bland is the co-Founder and Chief Science Officer of Chemosense. He has broad training in cell and molecular biology with specific training and expertise in the areas of neuroscience, receptor trafficking, signal transduction pathways, drug resistance, and cancer biology. He leveraged this extensive expertise to develop the power therapeutic that is at the core of Chemosense. He is passionate at give back to the community and educating future scientists in the life and biomedical sciences at the high school and college level through volunteering to lead laboratory sessions for high school students in underrepresented populations.
Boyang (Jason) Wu
Dr. Wu is the co-Founder of Chemosense. He has a broad background in biochemistry and molecular biology, pharmacology and cancer biology, with specific training and expertise in prostate cancer research, data mining and analysis, and anti-cancer drug development and delivery. He is also an Assistant Professor in the Washington State University College of Pharmacy and Pharmaceutical Sciences and is committed to the nature of the collaborative research effort needed between Chemosense and Washington State University to transition Chemosense novel therapy to market.
Dr. Prestwich is on the Board of Chemosense. He has co-founded 10 life sciences companies in the past 25 years, served as CSO or science advisor for over 12 companies, has produced over 40 issued patents, and over 650 scholarly papers and chapters in the life sciences. As a crucial advisor for both the scientific and business sides of operation, he is essential to the success of Chemosense powerful new therapy.